Jiang et al., 2020 - Google Patents
Identification of osteogenic progenitor cell-targeted peptides that augment bone formationJiang et al., 2020
View HTML- Document ID
- 18034150092779643720
- Author
- Jiang M
- Liu R
- Liu L
- Kot A
- Liu X
- Xiao W
- Jia J
- Li Y
- Lam K
- Yao W
- Publication year
- Publication venue
- Nature communications
External Links
Snippet
Activation and migration of endogenous mesenchymal stromal cells (MSCs) are critical for bone regeneration. Here, we report a combinational peptide screening strategy for rapid discovery of ligands that not only bind strongly to osteogenic progenitor cells (OPCs) but …
- 230000002188 osteogenic 0 title abstract description 56
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1841—Transforming growth factor [TGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Jiang et al. | Identification of osteogenic progenitor cell-targeted peptides that augment bone formation | |
Vi et al. | Macrophage cells secrete factors including LRP1 that orchestrate the rejuvenation of bone repair in mice | |
Shi et al. | Vasoactive intestinal peptide stimulates bone marrow-mesenchymal stem cells osteogenesis differentiation by activating Wnt/β-catenin signaling pathway and promotes rat skull defect repair | |
Zhang et al. | Acceleration of fracture healing by overexpression of basic fibroblast growth factor in the mesenchymal stromal cells | |
Fischer et al. | Calcium and vitamin-D deficiency marginally impairs fracture healing but aggravates posttraumatic bone loss in osteoporotic mice | |
Peng et al. | Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis | |
Alshenibr et al. | Anabolic role of lysyl oxidase like-2 in cartilage of knee and temporomandibular joints with osteoarthritis | |
Liang et al. | Inhibition of osteoblastic Smurf1 promotes bone formation in mouse models of distinctive age-related osteoporosis | |
Fu et al. | Kindlin-2 regulates skeletal homeostasis by modulating PTH1R in mice | |
Yu et al. | Decreased angiogenic and increased apoptotic activities of bone microvascular endothelial cells in patients with glucocorticoid-induced osteonecrosis of the femoral head | |
Rivera et al. | Local injections of β-NGF accelerates endochondral fracture repair by promoting cartilage to bone conversion | |
Yang et al. | A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice | |
Xu et al. | Induction of osteogenesis by bone-targeted Notch activation | |
Grenier et al. | BMP-9 expression in human traumatic heterotopic ossification: a case report | |
CN105229028A (en) | Be used for the treatment of the method for osteogenesis imperfecta | |
Kuek et al. | NPNT is expressed by osteoblasts and mediates angiogenesis via the activation of extracellular signal-regulated kinase | |
Suh et al. | Intracellular delivery of cell-penetrating peptide-transcriptional factor fusion protein and its role in selective osteogenesis | |
Peng et al. | Noggin improves bone healing elicited by muscle stem cells expressing inducible BMP4 | |
Matta et al. | NTG-101: a novel molecular therapy that halts the progression of degenerative disc disease | |
Thieltges et al. | Characterization of a drug-targetable allosteric site regulating vascular endothelial growth factor signaling | |
Yukata et al. | Continuous infusion of PTH1–34 delayed fracture healing in mice | |
Asari et al. | Structural basis for the effective myostatin inhibition of the mouse myostatin prodomain-derived minimum peptide | |
Zhang et al. | Osthole promotes endochondral ossification and accelerates fracture healing in mice | |
Okubo et al. | Expression of bone morphogenetic protein in the course of osteoinduction by recombinant human bone morphogenetic protein‐2 | |
Yea et al. | Tppp3+ synovial/tendon sheath progenitor cells contribute to heterotopic bone after trauma |